In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

Blood Cancer Journal, Published online: 15 April 2024; doi:10.1038/s41408-024-01046-2In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease

Source: Blood Cancer Journal - April 15, 2024 Category: Hematology Authors: Thomas Lund Michael Tveden Gundesen Annette Juul Vangsted Carsten Helleberg Einar Hauk ås Trine Silkj ær Jon Thor Asmussen Elena Manuela Teodorescu Bo Amdi Jensen Tobias Schmidt Sl ørdahl Hareth Nahi Anders Waage Niels Abildgaard Fredrik Schjesvold Source Type: research